BioCentury
ARTICLE | Financial News

ProQR sets IPO range

September 9, 2014 2:14 AM UTC

ProQR Therapeutics B.V. (Leiden, the Netherlands) set terms for its IPO on NASDAQ. The company plans to sell 6.3 million shares at $11-$13. At the $12 midpoint, the company would raise $75 million and be valued at $251.6 million. ProQR filed to raise up to $75 million last month. Leerink Partners; Deutsche Bank; JMP Securities; and H.C. Wainwright are underwriters. ...